Ember Therapeutics' Series A Round

Ember Therapeutics raised a round of funding on December 16, 2011. Investors include Third Rock Ventures.

Ember Therapeutics, formerly Adipothermics, is a product-focused company focuses in brown fat biology and insulin sensitization for the treatment of metabolic disease. Ember's approach leverages recen…

Articles about Ember Therapeutics' Series A Round: